Drugs / DTP/HB/Hib Vaccine
DTP/HB/Hib Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01986335 | Aug 2012 → Jan 2013 | — | PT Bio Farma | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DTP/HB/Hib Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01986335 ↗ |
| Known as | DPT/HB/Hib vaccine (Bio Farma) | “DPT/HB/Hib vaccine (Bio Farma)” NCT01986335 ↗ |
| Known as | DTP-HB-Hib | “We aimed at analyzing immunogenicity, safety, and consistency of a new combined DTP-HB-Hib (diphtheria-tetanus-pertussis-Hepatitis B-Haemophilus influenza B) vaccine.” PMID 26686508 ↗ Dec 2015 |
| Modality | Vaccine | “DTP-HB-Hib (diphtheria-tetanus-pertussis-Hepatitis B-Haemophilus influenza B) vaccine” PMID 26686508 ↗ Dec 2015 |